Market Overview

Jim Cramer Weighs In On Valeant, Corning And Synergy Pharmaceuticals

Share:
Related VRX
32 Biggest Movers From Yesterday
32 Stocks Moving In Thursday's Mid-Day Session
' Stocks Move on Thursday (GuruFocus)
Related GLW
Optical Stocks In Focus Following Apple's Deal With Finisar
Corning Signs Deal To Buy 3M's Communication Unit

Jim Cramer spoke on CNBC's Mad Money about Valeant Pharmaceuticals Intl Inc (NYSE: VRX). He thinks the company should do an equity offering to reduce its huge debt. There is still a large short position in the stock and some investors decided to cover it, because the downside is now quantified. He doesn't see Valeant as a good long position.

Cramer thinks Corning Incorporated (NYSE: GLW) is having a good run and the stock is a buy.

Cramer can't recommend Synergy Pharmaceuticals Inc (NASDAQ: SGYP) for anything other than a speculation. It's still in an early stage and it didn't report a good quarter.

Posted-In: Mad MoneyCNBC Jim Cramer Media

 

Related Articles (GLW + SGYP)

View Comments and Join the Discussion!